» Articles » PMID: 34932460

Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020

Overview
Date 2021 Dec 21
PMID 34932460
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis E virus (HEV) is the major cause of acute viral hepatitis in several countries in Europe. HEV is acquired mainly by consumption of contaminated pork but can also be transmitted through blood transfusion. HEV infection is usually self-limited but can become persistent in immunocompromised persons. During the first 30 months of HEV RNA universal screening of blood donations in Catalonia, Spain, we identified 151 HEV RNA-positive donations (1/4,341 blood donations). Most infected donors reported consumption of pates and sausages, and 58% were negative for HEV IgM and IgG. All HEV isolates belonged to genotype 3. All infected donors spontaneously resolved the infection, and no neurologic symptoms and reinfections were observed after 1 year of follow-up. Since the implementation of HEV RNA universal screening, no new cases of transfusion-transmitted HEV infection were reported. Our data indicate HEV screening of blood donations provides safer blood for all recipients, especially for immunosuppressed persons.

Citing Articles

HEV in Blood Donors in Switzerland: The Route to Safe Blood Products.

Serricchio M, Gowland P, Widmer N, Stolz M, Niederhauser C Pathogens. 2024; 13(10).

PMID: 39452782 PMC: 11510004. DOI: 10.3390/pathogens13100911.


Assessment of Hepatitis E virus transmission risks: a comprehensive review of cases among blood transfusion recipients and blood donors.

Singson S, Shastry S, Sudheesh N, Chawla K, Madiyal M, Kandasamy D Infect Ecol Epidemiol. 2024; 14(1):2406834.

PMID: 39421644 PMC: 11486055. DOI: 10.1080/20008686.2024.2406834.


Hepatitis E virus infections in German blood donors: results of 8 years of screening, 2015 to 2022.

Plumers R, Dreier J, Knabbe C, Gomer A, Steinmann E, Todt D Euro Surveill. 2024; 29(24).

PMID: 38873797 PMC: 11177570. DOI: 10.2807/1560-7917.ES.2024.29.24.2300665.


Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018-2020.

Niederhauser C, Gowland P, Widmer N, El Dusouqui S, Mattle-Greminger M, Gottschalk J Viruses. 2024; 16(5).

PMID: 38793625 PMC: 11125967. DOI: 10.3390/v16050744.


Hepatitis E Virus Infection in Voluntary Blood Donors in the Russian Federation.

Potemkin I, Kyuregyan K, Karlsen A, Isaeva O, Kichatova V, Lopatukhina M Viruses. 2024; 16(4).

PMID: 38675869 PMC: 11054373. DOI: 10.3390/v16040526.


References
1.
Riveiro-Barciela M, Rodriguez-Frias F, Buti M . Hepatitis E virus: new faces of an old infection. Ann Hepatol. 2013; 12(6):861-70. View

2.
Slot E, Hogema B, Riezebos-Brilman A, Kok T, Molier M, Zaaijer H . Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill. 2013; 18(31). DOI: 10.2807/1560-7917.es2013.18.31.20550. View

3.
Gallian P, Couchouron A, Dupont I, Fabra C, Piquet Y, Djoudi R . Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors. Transfusion. 2017; 57(1):223-224. DOI: 10.1111/trf.13889. View

4.
Dreier J, Knabbe C, Vollmer T . Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose. Front Med (Lausanne). 2018; 5:5. PMC: 5799287. DOI: 10.3389/fmed.2018.00005. View

5.
Riveiro-Barciela M, Rando-Segura A, Barreira-Diaz A, Bes M, Ruzo S, Piron M . Unexpected long-lasting anti-HEV IgM positivity: Is HEV antigen a better serological marker for hepatitis E infection diagnosis?. J Viral Hepat. 2020; 27(7):747-753. DOI: 10.1111/jvh.13285. View